ANALISYS OF RISK FACTORS IN HYPERTENSIVE PATIENTS IN BRANIK
Abstract
Background. The goal of this cross sectional study was to determine the prevalence of hypertension among the habitants of Branik and the presence of other risk factors, connected with hypertension.
Methods. Between December 1987 and December 1988 the authors examined 745 persons older than 20 years, 60% of whole population in Branik. Examination included history, clinical examination, blood pressure and other laboratory measurements.
Results. 23.4% of examined persons take antihypertensive drugs or are on low salt diet. The percent of hypertensive patients rises with age: from 2.3% (age 20–29) to 60.6% (age 80– 89). Most of hypertensive patients have moderate hypertension – 44.3%. The percent of hypertensive patients with normal body weight (NBW) is significantly lower than the percent of normotensive persons with NBW (p < 0.01). Among the persons with more than 130% of ideal body weight, there is significantly more hypertensive patients than normotensives (p < 0.01). The proportion of hypertensive patients, who never add salt to the food, is significantly greater than the proportion of normotensive patients of the same group (p < 0.01). There are more heavy drinkers among hypertensive patients than normotensive persons. There are less cigarette smokers among hypertensive persons than normotensive. 4% of examined persons have diabetes mellitus. 60% of diabetics have also hypertension. 10.3% of hypertensive persons have diabetes mellitus.
Conclusions. The prevalence of arterial hypertension was relatively high – 23.4%. The percent of hypertensive patients, who are overweight, is also higher than the percent of normotensive participants. Surprisingly, salt intake habits are healthier in hypertensive patients than in normotensive participants
Downloads
References
2. Epstein FH, Eckoff RD. The epidemiology of high blood pressure – geographic distribution and etiological factors. In: Stamler J et al. The epidemiology of hypertension. New York: Grune & Stratton, 1967: 155–63.
3. Page LB. Epidemiological evidence on etiology of human hypertension and its possible prevention. Am Heart J 1976; 91: 527–34.
4. Build and blood pressure study. Chicago: Society of Actuaries, 1959.
5. McGee D, Gordon T, Kannel WB. A general cardiovascular risk profile: The Framingham study. Am J Cardiol 1976; 38: 46–51.
6. Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the pooling project. J Chronic Dis 1978; 31: 201–6.
7. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham study, 18-year follow-up. In: Framingham study: An epidemiological investigation of cardiovascular disease. Am J Cardiol 1976; 33: 38–8.
8. Gordon T, Kannel WB. Predisposition to atherosclerosis in the head, heart and legs. The Framingham study. JAMA 1972; 221: 661–6.
9. Leren P. Opening remarks: Hypertension and risk factor concept. Am Heart J 1983; 106: 1190–206.
10. Kannel WB. Some lessons in cardiovascular epidemiology from Framingham. Am J Cardiol 1987; 37: 269–82.
11. Kannel WB, Castelli WP, McNamara PM. Cigarette smoking and risk of coronary heart disease. Epidemiologic clues to pathogenesis. The Framingham study. Natl Cancer Inst Mongr 1968; 28: 9–20.
12. Dahl LK. Salt and hypertension. Am J Clin Nutrition 1972; 25: 231–44.
13. Maill WE. Follow-up study of arterial pressure in the population of a Welsh mining valley. Br Med J 1959; 2: 1204–12.
14. Dawber TR et al. Environmental factors in hypertension. In: Essential hypertension. Heidelberg: Springer Verlag, 1960: 225–5.
15. Swaye PS, Gifford RW, Berrettoni JN et al. Dietary salt and essential hypertension. Am J Cardiol 1972; 29: 33–8.
16. Sasaki N. The relationship of salt intake to hypertension in the Japanese. Geriatrics 1969; 19: 735–42.
17. Schmieder RE, Messerli FH. Obesity and hypertension. In: Essential hypertension. Med Clin North Am 1987; 114: 813–8.
18. Frohlich ED. The problem of obesity and hypertension. Hypertension 1983; 5: 71–8.
19. Kannel WB et al. Relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med 1978; 67: 48–57.
20. Messerli FH. Obesity in hypertension: How innocent a bystander? Am J Med 1984; 77: 1077–82.
21. Metropolitan Life Insurance Company. Factors in mortality from cardiovascular disease. Salt Bull Metrop Life Insur Comp 1961; 42: 8–31.
22. Schmieder RE, Messerli FH. Is there a direct relationship between obesity and hypertension? Pract Cardiol 1986; 12: 68–74.
23. Stamler R, Stamler J, Riedlinger WF, Algera G, Roberts RH. Weight and blood pressure. Findings in hypertension screening in one million Americans. JAMA 1978; 240: 1607–10.
24. Maill WE, Chinn S. Blood pressure and aging: results of a fifteen to seventeen years follow-up study in South Wales. Clin Sci Mol Med 1973; 45: 23–8.
25. Kahn HA, Medalie JH, Neufeld NH, Riss E, Goldbourt U. The incidence of hypertension and associated factors: The Israel ischemic heart study. Am Heart J 1972; 84: 171–82.
26. Heyden S, Bartel AG, Hames CG, McDonough JR. Elevated blood pressure in adolescents, Evans County, Georgia. JAMA 1969; 209: 1683–9.
27. Boyle E. Biologic patterns in hypertension by race, sex, body weight and skin color. JAMA 1970; 213: 1637–43.
28. Ulrych M, Tauber J, Shapiro AP. Long term relationships between blood pressure, age and body weight in steelmill workers. Clin Sci Mol Med 1973; 45: 173–81.
29. Johnson BC, Karunas TM, Epstein FH. Longitudinal change in blood pressure in individuals, families and social groups. Clin Sci Mol Med 1973; 103: 1521–7.
30. Goldman AG, Varady PD, Franklin SS. Body habitus and serum holesterol in essential hypertension and renovascular hypertension. JAMA 1972; 221: 378–83.
31. Harlan WR et al. A thirty year study of a blood pressure in white male cohort. In: Onesti G et al. Hypertension, mechanisms and management. New York, 1973: 85–93.
32. Kannel WB, Dawber TR. Hypertensive cardiovascular disease. The Framingham Study. In: Onesti G et al. Hypertension, mechanisms and management. New York, 1973: 93–105.
33. Chiang BN, Perlman LV, Epstein FH. Overweight and hypertension. Circulation 1969; 39: 403–21.
34. MacMahon SW, Blacket RB, MacDonald GJ, Hall W. Obesity, alcohol consumption and blood pressure in Australian men and women. J Hypertension 1984; 2: 85–91.
35. Reisin E, Abel R, Modan M, Silverberg DS et al. Hypertension and body weight. N Engl J Med 1978; 29: 48–50.
36. Ramsay LE, Ramsay HM, Davies DL, Winchester J et al. Weight reduction in a blood pressure clinic. Br Med J 1978; 2: 244–5.
37. Ramsay LE. Liver disfunction in hypertension. Lancet 1977; 2: 111–4.
38. Beevers DG. Alcohol and hypertension. Lancet 1977; 2: 114–5.
39. Klatsky AL, Friedman GD, Siegelaub AS, Gerard MJ. Alcohol consumption and blood pressure. N Engl J Med 1977; 296: 1194–200.
40. Gordon T, Kannel WB. The Framingham Study. An epidemiological investigation of cardiovascular disease. Sect. 1-26. Framingham. National Heart and Lung Institute, 1969–1970.
41. Jezeršek P. Arterijska hipertenzija. Med Razgl 1986; 26: Suppl 1.
42. Robinson SC, Brucer M. Range of normal blood pressure. Arch Intern Med 1993; 64: 409–44.
43. Epstein FH. Prevalence of chronic diseases and distribution of selected physiologic variables in a total community, Tecumseh, Michigan. Am J Epidemiology 1964; 81: 2385–91.
44. Anon. Hypertension detection and follow-up program cooperative group blood pressure studies in 14 communities. A two-stage screen for hypertension. JAMA 1977; 237: 2385–91.
45. Shekelle RB. Hypertension and risk of stroke in elderly population. Stroke 1974; 5: 71–5.
46. Joint National Committee. Hypertension prevalence and the status of avarness, treatment and control in the United States. Final Report of the Subcommittee on definition and prevalence of the 1984 Joint National Committee. Hypertension 1985; 7: 457–68.
47. Kannel WB, Brand N, Skinner JJ, Dawber TR. Relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med 1967; 25: 48–59.
48. Robinson SC, Brucer M. Hypertension and obesity. J Lab Clin Med 1939; 25: 807–22.
49. Prior IAM et al. Sodium intake and blood pressure in two Polynesian populations. N Engl J Med 1968; 279: 515–20.
50. Phear DN. Salt intake in hypertension. Brit Med J 1959; 2: 515–23.
51. Maill WE. Follow-up study of arterial pressure in the population of a Welsh mining valley. Brit Med J 1959; 2: 1204–12.
52. Dawber TR et al. Environmental factors in hypertension. In: The epidemiology of hypertension. Chicago: Grune & Stratton, 1967.
53. Langford HG, Watson RL. Electrolytes, environment and blood pressure. Clin Sci Mol Med 1973; 45: 111–3.
54. Swaye PS, Gilford RW, Berrettoni JR. Dietary salt and arterial hypertension. Am J Cardiol 1972; 29: 33–8.
55. Sneckloth RE et al. Arterial pressure and hypertensive disease in West Indian negro population: report of surgery in St. Kitts, West Indies. Am Heart J 1962; 63: 607–28.
56. Dahl LK, Love RA. Etiological role of sodium chloride intake in essential hypertension in humans. JAMA 1957; 164: 397–400.
57. Fallis N et al. Gustatory tresholds in patients with hypertension. Nature 1962; 196: 74–5.
58. Dahl LK, Shackow E. Effects of chronic excess salt ingestion. Proc Soc Exp Biol Med 1966; 122: 952–7.
59. Luft FC. Sodium: complexities in a simple relationship. Hospital Practice 1988; 23: 73–80.
60. Dawber TR et al. Environmental factors in hypertension. Epidemiology of hypertension. New York: Grune & Stratton, 1967: 255–8.
61. Kannel WB, Sorlie P. Hypertension in Framingham. Epidemiology and control of hypertension. New York: Stratton Intercontinental Medical Book Corporation, 1974: 553–92.
62. Clarck VA, Chapman JM, Coulson AH. Effects of various factors on systolic and diastolic blood pressure in the Los Angeles Heart Study. J Chron Dis 1967; 20: 571–81.
63. D’Alonzo CA, Pell S. Cardiovascular disease among problem drinkers. J Ocup Med 1968; 10: 344–50.
64. Myrhed M. Alcohol consumption in relation to factors associated with ischemic heart disease. Acta Med Scand 1974; 567: Suppl: 1–93.
65. Dawber TR et al. The epidemiology of coronary heart disease. The Framingham enquiry. Proc Roy Soc Med 1962; 55: 265–72.
66. Edwards F et al. Arterial pressure in men over sixty. Clin Sci 1959; 18: 289– 97.
67. Maill WE, Oldham PD. Factors influencing arterial blood pressure in the general population. Clin Sci 1958; 17: 409–14.
68. Karvonen MJ, Keys A, Aravanis C, Blackburn H et al. Coronary heart disease: overweight and obesity as risk factors. Ann Intern Med 1972; 77: 15–27.
69. Tibblin G. High blood pressure in men aged 50. A population study of men born in 1913. Acta Med Scand 1967; Suppl 470: 1–84.
70. Conn JW. Hypertension, the potassium ion and impaired carbohidrate tolerance. N Engl J Med 1965; 273: 1135–43.
71. Munro HN. Survey of Scottish diabetic clinic. J Clin Endocr 1949; 9: 48–62.
72. Pell S, D’Alonzo CA. Some aspects of hypertension in diabetes mellitus. JAMA 1967; 202: 104–10.
73. Anon. Five year findings of the hypertension detection and follow-up program. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979; 242: 2562–71.
74. Joint National Committee on detection evaluation and treatment of high blood pressure. Report 1984. Arch Intern Med 1984; 144: 1045–57.
75. Drizid T, Dannenberg AL, Engel A. Blood pressure levels in persons 18–74 years of age in 1976–1980, and trends in blood pressure from 1960 to 1980 in the United States. Vital and Health statistics, Series 11, 234, DHHS Pub. No. 86–1684. Washington: National Center of Health Statistics, US Governement Printing Office, 1986.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
